Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts
Agency: Centers for Disease Control and Prevention - ERA
Assistance Listings
- 93.068 -- Chronic Diseases: Research, Control, and Prevention
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The primary purpose of this opportunity is to fund applicants with existing access to adult lupus patient populations and can extend current knowledge over 12-17 years from baseline. A second component of this funding opportunity will focus on the pediatric lupus - to advance existing knowledge of lupus in pediatric populations using an existing cohort of lupus patients. Because lupus is a rare condition, it is efficient to obtain new information from existing relevant cohorts with lupus. The research objectives among both adult and pediatric populations are to:
Examine the treatment (e.g.,...
medications including opioid; type; appropriateness; etc.) of people with lupus.
Determine health care access and gaps that people with lupus experience in addressing their varied health problems (e.g., general health problems as well as those for specific lupus outcomes, such as nephritis; transitions to adulthood).
Determine longer term natural history (severity, chronic pain, progression, morbidity, mortality, disability and quality of life, work/ school/activity interference, etc.) of people with lupus, including assessing potential genetic factors.
Examine other factors related to disparities in lupus outcomes (e.g., age, sex, and race/ethnic group).
Examine lupus comorbidities.
Eligibility
Eligible applicants
Government
- City or township governments
- Public and Indian housing authorities
- Federally recognized Native American tribal governments
- County governments
- State governments
- Special district governments
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Business
- Small businesses
- For-profit organizations other than small businesses
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Miscellaneous
- Unrestricted
Additional information
Special Eligibility. For an application to be considered, the application must be responsive to these Special Eligibility Requirements. If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process.
Component A: Epidemiology of Lupus Among the Adults
Applicants must have access to an existing and established baseline cohort of lupus patients that has been followed for at least 5 years.
The sample size of the cohort to be used for this study should include a minimum of 400 lupus participants.
If an applicant requests a funding amount greater than the ceiling of $900,000 (Section II. Award Information) for either Component (A or B) as indicated in Section II of this NOFO, HHS/CDC will consider the application non-responsive, and it will not enter into the review process. HHS/CDC will notify the applicant that the application did not meet the submission requirement.
Component B: Epidemiology of Lupus in the Pediatric Population
Applicants must have access to an existing and established baseline cohort of lupus patients that has been followed for at least 3 years.
The sample size of the cohort to be used for this study should include a minimum of 400 lupus participants.
If an applicant requests a funding amount greater than the ceiling of $900,000 (Section II. Award Information) for either Component (A or B) as indicated in Section II of this NOFO, HHS/CDC will consider the application non-responsive, and it will not enter into the review process. HHS/CDC will notify the applicant that the application did not meet the submission requirement.
Grantor contact information
Description
Sue Shaw
ResearchNOFO@cdc.gov
ResearchNOFO@cdc.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| Foa_Content_of_RFA-DP-22-002_Revised.pdf | Foa_Content_of_RFA-DP-22-002 Revised.pdf | Jan 6, 2022 03:11 PM UTC |
| Foa_Content_of_RFA-DP-22-002.pdf | Foa_Content_of_RFA-DP-22-002.pdf | Nov 4, 2021 07:15 PM UTC |
Link to additional information
--
Archived: February 18, 2022
Award
$26,400,000
Program Funding
6
Expected awards
$870,000
Award Minimum
$900,000
Award Maximum
Funding opportunity number:
RFA-DP-22-002
Cost sharing or matching requirement:
No
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
3
Posted date:
November 4, 2021
Archive date:
February 18, 2022
